Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Mar-23 7:37 PM View:  | Emergent BioSolutions, Inc. (EBS) | 02-Mar-23 | Grant | 18,462 | -- | -- | 22% 82.09K to 100.55K | |
| 02-Mar-23 2:41 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-23 | Payment of Exercise | 998 | $12.38 | $12,355.20 | (3%) 34.92K to 33.93K | |
| 27-Feb-23 8:22 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Feb-23 | Payment of Exercise | 812 | $13.71 | $11,132.50 | (2%) 34.49K to 33.68K | |
| 27-Feb-23 8:22 PM View: | Emergent BioSolutions, Inc. (EBS) | 23-Feb-23 | Payment of Exercise | 432 | $14.30 | $6,177.60 | (1%) 34.92K to 34.49K | |
| 10-Feb-23 8:34 PM View: | Emergent BioSolutions, Inc. (EBS) | 08-Feb-23 | Grant | 95 | -- | -- | < 1% 36.79K to 36.89K | |
| 10-Feb-23 8:34 PM View: | Emergent BioSolutions, Inc. (EBS) | 08-Feb-23 | Payment of Exercise | 1,964 | $13.25 | $26,023.00 | (5%) 36.89K to 34.92K | |
| 02-Mar-22 7:25 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Mar-22 | Grant | 50,145 | -- | -- | 136% 36.79K to 86.94K | |
| 02-Mar-22 7:25 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-22 | Payment of Exercise | 739 | $39.64 | $29,294.00 | (< 1%) 86.94K to 86.2K | |
| 25-Feb-22 5:17 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Feb-22 | Payment of Exercise | 828 | $42.47 | $35,165.20 | (2%) 37.62K to 36.79K | |
| 25-Feb-22 5:17 PM View: | Emergent BioSolutions, Inc. (EBS) | 23-Feb-22 | Payment of Exercise | 424 | $42.23 | $17,905.50 | (1%) 38.05K to 37.62K | |
| 24-Feb-22 6:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 22-Feb-22 | Grant | 1,836 | -- | -- | 5% 38.19K to 40.03K | |
| 24-Feb-22 6:49 PM View: | Emergent BioSolutions, Inc. (EBS) | 22-Feb-22 | Payment of Exercise | 1,980 | $42.23 | $83,615.40 | (5%) 40.03K to 38.05K | |
| 03-Mar-21 6:07 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Mar-21 | Option Exercise | 37,279 | $40.90 | $1,524,810.00 | 98% 38.19K to 75.47K | |
| 03-Mar-21 6:07 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Mar-21 | Market Option Sale (Planned) | 37,279 | $99.30 | $3,701,650.00 | (49%) 75.47K to 38.19K | |
| 26-Feb-21 5:18 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-21 | Payment of Exercise | 1,471 | $97.15 | $142,908.00 | (4%) 39.66K to 38.19K | |
| 26-Feb-21 5:18 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Feb-21 | Grant | 7,488 | -- | -- | 23% 33.02K to 40.51K | |
| 26-Feb-21 5:18 PM View: | Emergent BioSolutions, Inc. (EBS) | 24-Feb-21 | Payment of Exercise | 847 | $93.49 | $79,186.00 | (2%) 40.51K to 39.66K | |
| 11-Feb-21 9:24 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Feb-21 | Grant | 2,518 | -- | -- | 8% 32.69K to 35.2K | |
| 11-Feb-21 9:24 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Feb-21 | Payment of Exercise | 2,183 | $123.45 | $269,491.00 | (6%) 35.2K to 33.02K | |
| 21-Apr-20 6:12 PM View: | Emergent BioSolutions, Inc. (EBS) | 20-Apr-20 | Option Exercise | 17,009 | $30.86 | $524,898.00 | 50% 34.26K to 51.27K | |
| 21-Apr-20 6:12 PM View: | Emergent BioSolutions, Inc. (EBS) | 20-Apr-20 | Market Option Sale (Planned) | 17,009 | $69.00 | $1,173,620.00 | (33%) 51.27K to 34.26K | (38%) |
| 21-Apr-20 6:12 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-Apr-20 | Option Exercise | 20,414 | $26.45 | $539,950.00 | 60% 34.26K to 54.67K | |
| 21-Apr-20 6:12 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-Apr-20 | Market Option Sale (Planned) | 20,414 | $65.00 | $1,326,910.00 | (37%) 54.67K to 34.26K | (46%) |
| 08-Apr-20 8:22 PM View: | Emergent BioSolutions, Inc. (EBS) | 06-Apr-20 | Market Sale (Planned) | 7,972 | $60.00 | $478,320.00 | (19%) 42.23K to 34.26K | (58%) |
| 27-Feb-20 9:23 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-20 | Payment of Exercise | 409 | $58.42 | $23,893.80 | (< 1%) 42.64K to 42.23K | (63%) |
| 27-Feb-20 9:23 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-20 | Payment of Exercise | 997 | $59.91 | $59,730.30 | (2%) 43.63K to 42.64K | (59%) |
| 27-Feb-20 9:23 PM View: | Emergent BioSolutions, Inc. (EBS) | 25-Feb-20 | Grant | 11,394 | -- | -- | 35% 32.24K to 43.63K | |
| 13-Mar-19 5:10 PM View: | Emergent BioSolutions, Inc. (EBS) | 11-Mar-19 | Market Sale (Planned) | 2,430 | $56.93 | $138,340.00 | (7%) 34.67K to 32.24K | (67%) |
| 04-Mar-19 6:40 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Mar-19 | Market Sale (Planned) | 2,024 | $58.20 | $117,797.00 | (6%) 36.69K to 34.67K | (63%) |
| 28-Feb-19 7:38 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-19 | Payment of Exercise | 812 | $58.71 | $47,672.50 | (2%) 38.52K to 37.71K | (62%) |
| 04-Mar-19 6:40 PM View: | Emergent BioSolutions, Inc. (EBS) | 28-Feb-19 | Market Sale (Planned) | 1,019 | $57.92 | $59,022.30 | (3%) 37.71K to 36.69K | (64%) |
| 28-Feb-19 7:38 PM View: | Emergent BioSolutions, Inc. (EBS) | 27-Feb-19 | Payment of Exercise | 409 | $57.98 | $23,713.80 | (1%) 38.93K to 38.52K | (64%) |
| 28-Feb-19 7:38 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-19 | Grant | 10,162 | -- | -- | 35% 29.25K to 39.41K | |
| 28-Feb-19 7:38 PM View: | Emergent BioSolutions, Inc. (EBS) | 26-Feb-19 | Payment of Exercise | 481 | $61.01 | $29,345.80 | (1%) 39.41K to 38.93K | (56%) |
| 05-Nov-18 5:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 02-Nov-18 | Option Exercise | 6,168 | $25.62 | $158,024.00 | 21% 29.25K to 35.42K | |
| 05-Nov-18 5:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 02-Nov-18 | Market Option Sale (Planned) | 6,168 | $64.50 | $397,836.00 | (17%) 35.42K to 29.25K | (47%) |
| 05-Nov-18 5:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Nov-18 | Option Exercise | 2,011 | $25.62 | $51,521.80 | 7% 29.25K to 31.26K | |
| 05-Nov-18 5:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Nov-18 | Market Option Sale (Planned) | 2,011 | $63.50 | $127,698.00 | (6%) 31.26K to 29.25K | (50%) |
| 19-Oct-18 5:06 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-Oct-18 | Option Exercise | 314 | $25.62 | $8,044.68 | 1% 29.25K to 29.57K | |
| 19-Oct-18 5:06 PM View: | Emergent BioSolutions, Inc. (EBS) | 17-Oct-18 | Market Option Sale (Planned) | 314 | $61.50 | $19,311.00 | (1%) 29.57K to 29.25K | (55%) |
| 17-Oct-18 4:19 PM View: | Emergent BioSolutions, Inc. (EBS) | 16-Oct-18 | Option Exercise | 10,005 | $25.62 | $256,328.00 | 34% 29.25K to 39.26K | |
| 17-Oct-18 4:19 PM View: | Emergent BioSolutions, Inc. (EBS) | 16-Oct-18 | Market Option Sale (Planned) | 9,344 | $62.27 | $581,829.00 | (24%) 39.26K to 29.91K | (53%) |
| 17-Oct-18 4:19 PM View: | Emergent BioSolutions, Inc. (EBS) | 16-Oct-18 | Market Sale (Planned) | 661 | $62.27 | $41,158.90 | (2%) 29.91K to 29.25K | (53%) |
| 17-Oct-18 4:19 PM View: | Emergent BioSolutions, Inc. (EBS) | 15-Oct-18 | Option Exercise | 12,330 | $25.62 | $315,895.00 | 41% 29.91K to 42.24K | |
| 17-Oct-18 4:19 PM View: | Emergent BioSolutions, Inc. (EBS) | 15-Oct-18 | Market Option Sale (Planned) | 12,991 | $60.12 | $781,038.00 | (31%) 42.24K to 29.25K | (58%) |
| 13-Mar-18 5:57 PM View: | Emergent BioSolutions, Inc. (EBS) | 12-Mar-18 | Market Sale (Planned) | 5,842 | $52.82 | $308,574.00 | (16%) 35.76K to 29.91K | (80%) |
| 13-Mar-18 5:57 PM View: | Emergent BioSolutions, Inc. (EBS) | 09-Mar-18 | Payment of Exercise | 974 | $51.84 | $50,492.20 | (3%) 36.73K to 35.76K | (83%) |
| 09-Mar-18 5:24 PM View: | Emergent BioSolutions, Inc. (EBS) | 07-Mar-18 | Payment of Exercise | 2,843 | $50.43 | $143,372.00 | (7%) 39.57K to 36.73K | (89%) |
| 09-Mar-18 5:24 PM View: | Emergent BioSolutions, Inc. (EBS) | 07-Mar-18 | Option Exercise | 6,573 | $22.03 | $144,803.00 | 20% 33.0K to 39.57K | |
| 01-Mar-18 5:03 PM View: | Emergent BioSolutions, Inc. (EBS) | 01-Mar-18 | Market Sale (Planned) | 1,898 | $49.50 | $93,951.00 | (5%) 34.9K to 33.0K | (92%) |